Oct 25 (Reuters)-
Kainos Laboratories Inc
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2018 Sep 30, 2017 Mar 31, 2019
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 2.25 2.01 4.80
(+12.4 pct) (-14.8 pct) (+9.4 pct)
Operating 307 mln 161 mln 500 mln
(+89.8 pct) (-34.1 pct) (+9.6 pct)
Recurring 324 mln 180 mln 500 mln
(+80.4 pct) (-19.9 pct) (+4.8 pct)
Net 219 mln 126 mln 350 mln
(+72.9 pct) (-13.4 pct) (+25.9 pct)
EPS 53.59 yen 30.38 yen 89.89 yen
Ann Div 12.50 yen 12.50 yen
-Q2 div NIL NIL
-Q4 div 12.50 yen 12.50 yen
NOTE - Kainos Laboratories Inc.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4556.T